Spain pushes for higher colonoscopy testing rates:
This article was originally published in Clinica
Executive Summary
Prompter access to testing for colorectal cancer and higher survival rates are the ultimate aim of a Spanish public awareness booklet, published to mark the culmination of European colorectal cancer month. Among the topics featured in the Roche-sponsored guide are the early signs of disease and the importance of a prompt assessment using colonoscopy. Spain records annually some 22,000 new cases, of which 20% are at a metastatic stage, according to Europacolon Espana, the country's leading awareness and lobby group in this area. Greater public awareness should have a significant impact, it believes, on reducing this proportion of late diagnoses. Three-quarters of all cases appear in the 60-80 year age group and 90% of cases are aged over 50 (see Clinica No 1300, page 8).
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.